For immediate release |
24 August 2009 |
ALLIANCE PHARMA PLC
('the Company')
Major Interest in Shares
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was informed on 24 August 2009
that Nigel Wray purchased, on 24 August 2009, 4,500,000 ordinary shares of 1p each in the Company. The Company was also informed on 24 August 2009 that Mr Wray purchased a further 300,000 ordinary shares during July 2009.
Mr Wray's resultant shareholding is 21,469,995 ordinary shares, equivalent to 11.1% of the Company's issued share capital.
Mr Wray's ordinary shares are held as follows:
Nominee |
Number of ordinary shares |
Pershing Keen Nominees Limited Smith & Williamson Nominees Limited Roy Nominees Limited |
9,299,407 50,000 12,120,588 |
For further information:
Alliance Pharma plc
|
+ 44 (0) 1249 466966
|
John Dawson, Chief Executive
|
|
Richard Wright, Finance Director
|
|
|
|
|
|
Buchanan Communications
|
+ 44 (0) 20 7466 5000
|
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic
|
|
|
|
Numis Securities Limited
|
+ 44 (0) 20 7260 1000
|
Nominated Adviser: Michael Meade / Brent Nabbs
|
|
Corporate Broking: David Poutney
|
|